Long‐term treatment of spasticity with onabotulinumtoxinA in intellectually and developmentally disabled adults.
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 21 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.